Sigachi Industries Q1 Results: Net profit rebounds to ₹8.14 crore

2 min read     Updated on 13 Aug 2026, 07:24 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Sigachi Industries returned to profitability in Q1FY26 with a consolidated net profit of ₹8.14 crore, reversing a ₹100.97 crore loss from the prior year. Revenue dipped slightly to ₹121.27 crore. The board forfeited ₹22.87 crore worth of lapsed convertible warrants and proposed re-appointments for two independent directors.

powered bylight_fuzz_icon
48174883

*this image is generated using AI for illustrative purposes only.

Sigachi Industries Limited ( sigachi industries ) reported a consolidated net profit of ₹8.14 crore for the quarter ended June 30, 2026, marking a sharp turnaround from the ₹100.97 crore loss recorded in the corresponding period of FY25. The company’s standalone net profit also recovered to ₹6.50 crore, compared to a ₹99.14 crore loss in Q1FY25.

Consolidated revenue from operations stood at ₹121.27 crore, down slightly from ₹128.25 crore in Q1FY25. Standalone revenue was ₹98.28 crore, lower than the ₹110.98 crore reported in the prior year quarter. The previous year’s results were significantly impacted by exceptional losses of ₹121.01 crore, whereas no such exceptional items were reported in the current quarter.

Financial Performance

The company’s profitability improved across both standalone and consolidated metrics. Consolidated profit before tax reached ₹10.09 crore, up from a loss of ₹100.99 crore in Q1FY25. Standalone profit before tax was ₹7.79 crore, compared to a loss of ₹99.20 crore in the same period last year.

Metric Consolidated Q1FY26 (₹ cr) Consolidated Q1FY25 (₹ cr) Standalone Q1FY26 (₹ cr) Standalone Q1FY25 (₹ cr)
Revenue from Operations 121.27 128.25 98.28 110.98
Profit Before Tax 10.09 (100.99) 7.79 (99.20)
Net Profit/Loss 8.14 (100.97) 6.50 (99.14)
EPS (Basic) ₹0.18 (₹2.63) ₹0.17 (₹2.59)

Segmental Insights

The pharmaceuticals segment remained the primary revenue driver. Consolidated revenue from pharmaceuticals was ₹108.21 crore, while the operational and management segment contributed ₹13.06 crore. In standalone figures, pharmaceuticals revenue stood at ₹85.22 crore.

Corporate Actions

The Board of Directors, meeting on August 13, 2026, approved the lapse and forfeiture of convertible warrants issued under SEBI ICDR Regulations 2018. A total of 3.51 crore warrants lapsed as holders failed to exercise conversion options within the 18-month tenure. Consequently, an amount of ₹22.87 crore stands forfeited. The warrants were originally allotted on August 10, 2023, at an issue price of ₹26.1 per warrant.

Additionally, the board recommended the re-appointment of Ms. Dhanalakshmi Guntaka and Mr. Janardhana Reddy Yeddula as independent directors for five-year terms, subject to shareholder approval at the ensuing annual general meeting. Mr. Chidambarnathan, retiring by rotation, also offered himself for re-appointment.

What the Numbers Show

The current quarter’s profitability is entirely operational, devoid of the massive exceptional losses that dragged down FY25 results. While revenue declined modestly year-on-year, the absence of exceptional items allowed the company to return to positive net earnings, highlighting a stabilization in core operations despite softer top-line growth.

Historical Stock Returns for Sigachi Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-3.41%+4.69%+11.75%+18.00%-14.09%-55.97%

Will Sigachi Industries be able to sustain its operational profitability in Q2FY26 given the year-on-year decline in revenue from operations?

How might the forfeiture of ₹22.87 crore from lapsed convertible warrants impact the company's capital structure and future fundraising strategies?

What specific operational improvements or cost-cutting measures contributed to the turnaround from a ₹100.97 crore loss to a profit, excluding the one-time exceptional items?

Sigachi Industries postpones Q1FY27 earnings call due to unavoidable circumstances

1 min read     Updated on 26 Jul 2026, 01:06 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Sigachi Industries Limited has delayed its earnings call for the quarter ended June 30, 2026, from July 27, 2026, due to unavoidable circumstances. The company will provide a revised date later, with the insider trading window remaining closed until 48 hours post-result announcement.

powered bylight_fuzz_icon
46177618

*this image is generated using AI for illustrative purposes only.

Sigachi Industries Limited has postponed its earnings call for the first quarter of FY27 (Q1FY27), which was originally scheduled for July 27, 2026. The company cited unavoidable circumstances as the reason for the delay. This update clarifies that while the board meeting to approve the unaudited financial results remains on track, the subsequent investor communication event has been rescheduled. Investors awaiting management commentary on the quarterly performance must now wait for an official intimation regarding the new date.

The intimation was communicated to the stock exchanges via a letter dated July 26, 2026, signed by Vivek Kumar, Company Secretary & Compliance Officer. This filing serves as a continuation of the earlier notice issued on July 21, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that it will inform the National Stock Exchange of India Limited (NSE) and the Bombay Stock Exchange (BSE) of the revised date for the earnings call in due course.

Revised Timeline for Investor Communications

The original schedule included an earnings conference call facilitated by Go India Advisors, set for July 27, 2026, at 4:30 PM IST. Senior management, including Amit Raj Sinha, Managing Director & CEO, and O. Subbarami Reddy, Chief Financial Officer, were expected to participate. With the call postponed, the timing for this specific engagement is now uncertain. However, the closure of the trading window for insiders remains in effect until 48 hours after the announcement of the unaudited financial results, ensuring compliance with regulatory norms regarding insider trading prevention.

Detail: Information
Original Earnings Call Date: July 27, 2026
Status: Postponed
Reason: Unavoidable circumstances
Results Period: Quarter ended June 30, 2026 (Q1FY27)
Trading Window: Closed until 48 hours after result announcement

Impact on Market Expectations

While the postponement affects the timeline for investor interaction, it does not necessarily indicate a delay in the release of the financial results themselves, provided the board meeting proceeds as initially planned. The adherence to SEBI Listing Regulations ensures transparency regarding the procedural change. Market participants are advised to monitor official exchange filings for the updated schedule of the earnings call and any subsequent announcements regarding the Q1FY27 financial outcomes.

Historical Stock Returns for Sigachi Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-3.41%+4.69%+11.75%+18.00%-14.09%-55.97%

What specific operational or strategic factors might constitute the 'unavoidable circumstances' cited by Sigachi Industries for postponing the Q1FY27 earnings call?

How could the delay in management commentary impact short-term investor sentiment and stock volatility before the unaudited results are officially released?

Will the postponed earnings call provide clarity on Sigachi's capacity utilization and pricing trends in the specialty paper segment for the upcoming quarter?

More News on Sigachi Industries

1 Year Returns:-14.09%